January 2014
Request for Declaratory Relief Dismissed Under the First-to-File Rule When Infringement and Invalidity Claims to Be Tried in the Earlier-Filed Case
[Appealed from C.D. Cal., Judge Guildford]
Cost of Creating Produced Duplicates Are Included Under 28 U.S.C. § 1920(4), but Preparatory or Ancillary Costs Associated with Duplication Are Not
[Appealed from N.D. Ga., Judge Thrash]
ITC Lacks Authority to Issue Exclusion Orders Based on Theory of Induced Infringement Where Underlying Direct Infringement Occurs Postimportation
[Appealed from ITC]
Invalidity Not Proven by Feature in Prior Art Device and Domestic Industry Requirement Satisfied by Investment in Software Specifically Tailored for Use in Patented Mobile Device
[Appealed from ITC]
Totality of Circumstances, Including Objective Baselessness, Should Be Considered When Determining Subjective Bad Faith Under 35 U.S.C. § 285
[Appealed from N.D. Cal., Judge Illston]
Federal Food, Drug, and Cosmetic Act Does Not Preempt State’s Regulation of Prescription Drugs
[Appealed from C.D. Cal., Judge Selna]
Knowledge of a Goal Does Not Render Its Achievement Obvious
[Appealed from Board]
Abbreviations | |
ALJ | Administrative Law Judge |
ANDA | Abbreviated New Drug Application |
APA | Administrative Procedures Act |
APJ | Administrative Patent Judge |
Board | Patent Trial and Appeal Board (formerly the Board of Patent Appeals and Interferences) |
Commissioner | Commissioner of Patents and Trademarks |
CIP | Continuation-in-Part |
DJ | Declaratory Judgment |
DOE | Doctrine of Equivalents |
FDA | Food and Drug Administration |
IDS | Information Disclosure Statement |
ITC | International Trade Commission |
JMOL | Judgment as a Matter of Law |
MPEP | Manual of Patent Examining Procedure |
NDA | New Drug Application |
PCT | Patent Cooperation Treaty |
PTO | United States Patent and Trademark Office |
SJ | Summary Judgment |
TTAB | Trademark Trial and Appeal Board |